EMPIRIC ANTIBACTERIAL THERAPY AND COMMUNITY-ONSET BACTERIAL CO INFECTION IN PATIENTS HOSPITALIZED WITH COVID-19: A MULTI-HOSPITAL COHORT STUDY

Antibacterials may be initiated out of concern for bacterial co-infection in
patients with COVID-19. We determined prevalence and predictors of empiric antibacterial therapy and community-onset bacterial co-infections in hospitalized patients with COVID19.

EMPIRIC ANTIBACTERIAL THERAPY AND COMMUNITY-ONSET BACTERIAL CO-INFECTION IN PATIENTS HOSPITALIZED WITH COVID-19: A MULTI-HOSPITAL COHORT STUDY
Size: 730 KB